Items tagged with Treatment
Treatment Action Group statement on bedaquiline unaffordability (post with simple image)
Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.
TB CAB Statement (post with simple image)
TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction
Landmark TB trial identifies shorter-course treatment regimen (post with simple image)
Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.
SHINE trial on shorter treatment for children with minimal TB (post with simple image)
TB treatment can be shortened from six to four months in 80% of children.
First digital adherence technology in the GDF’s product catalog (post with simple image)
Smart medication container included in Stop TB Partnership's Global Drug Facility (GDF) product catalog.
TAG's 2020 Pipeline Report: TB chapters released (post with simple image)
Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.
Landmark TB trials results published in New England Journal of Medicine (post with simple image)
A shorter regimen containing rifapentine and moxifloxacin can cure TB in four months.
Page 84 of 84 · Total posts: 0←First 83 84